Dermira, Inc.

Dermira, Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Dermira is a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions. We are committed to understanding and addressing the needs of both patients and physicians, and using our experience and insight to identify and develop leading-edge medical dermatology clinical programs. Our goal is to help transform the way skin conditions are treated by serving as the bridge between unmet patient needs and the significant scientific advances being made in understanding skin biology. Learn more about who we are and what we do by visiting Dermira.com. Here are our community guidelines: https://bit.ly/2rH5IuL

Company Details

Employees
23
Founded
-
Address
275 Middlefield Road, #150, Menlo Park,ca 94025,united States
Phone
(650) 421-7200
Email
in****@****ira.com
Industry
Biotechnology
HQ
Menlo Park, CA
Looking for a particular Dermira, Inc. employee's phone or email?

Dermira, Inc. Questions

News

Dermira Announces Positive Topline Results from Phase 2b Study of Lebrikizumab in Patients with Atopic Dermatitis - GlobeNewswire

Dermira Announces Positive Topline Results from Phase 2b Study of Lebrikizumab in Patients with Atopic Dermatitis GlobeNewswire

A year after buyout, Lilly to shutter Dermira's Menlo Park facility and shed 163 jobs - Fierce Pharma

A year after buyout, Lilly to shutter Dermira's Menlo Park facility and shed 163 jobs Fierce Pharma

Lilly and Dermira Present New Lebrikizumab Phase 2b Clinical Data Showing Patients with Atopic Dermatitis Had Clinically Meaningful Improvements in Itch, Sleep and Quality of Life - PR Newswire

Lilly and Dermira Present New Lebrikizumab Phase 2b Clinical Data Showing Patients with Atopic Dermatitis Had Clinically Meaningful Improvements in Itch, Sleep and Quality of Life PR Newswire

FDA Grants Fast Track Status to Lebrikizumab for Atopic Dermatitis - Medical Professionals Reference

FDA Grants Fast Track Status to Lebrikizumab for Atopic Dermatitis Medical Professionals Reference

Ex-Dermira founders pick up $83M for Evommune to advance programs in-licensed from Lilly's Dermira - Fierce Biotech

Ex-Dermira founders pick up $83M for Evommune to advance programs in-licensed from Lilly's Dermira Fierce Biotech

Lilly to buy Dermira, challenging Sanofi and Regeneron’s Dupixent - BioPharma Dive

Lilly to buy Dermira, challenging Sanofi and Regeneron’s Dupixent BioPharma Dive

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline - statnews.com

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline statnews.com

Eli Lilly Acquires Dermatology Pharmaceutical Company Dermira For $1.1 Billion - WFYI

Eli Lilly Acquires Dermatology Pharmaceutical Company Dermira For $1.1 Billion WFYI

Dermira to Report Fourth Quarter 2018 Results and Host Conference Call on Tuesday, February 26, 2019 - GlobeNewswire

Dermira to Report Fourth Quarter 2018 Results and Host Conference Call on Tuesday, February 26, 2019 GlobeNewswire

Dermira to Report Third Quarter 2018 Results and Host Conference Call on Wednesday, November 7, 2018 - GlobeNewswire

Dermira to Report Third Quarter 2018 Results and Host Conference Call on Wednesday, November 7, 2018 GlobeNewswire

Dermira to Present at Cantor 2018 Global Healthcare Conference - GlobeNewswire

Dermira to Present at Cantor 2018 Global Healthcare Conference GlobeNewswire

Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire

Dermira and Christian Siriano Collaborate to Inspire People - GlobeNewswire

Dermira and Christian Siriano Collaborate to Inspire People GlobeNewswire

Dermira Announces “Life Unfolds” Direct-to-Consumer Campaign to Highlight QBREXZA™ (glycopyrronium) Cloth - GlobeNewswire

Dermira Announces “Life Unfolds” Direct-to-Consumer Campaign to Highlight QBREXZA™ (glycopyrronium) Cloth GlobeNewswire

Dermira Acquires Option to License Exclusive Rights for up to Three Early-Stage Programs from Takeda - GlobeNewswire

Dermira Acquires Option to License Exclusive Rights for up to Three Early-Stage Programs from Takeda GlobeNewswire

Dermira Enters into Agreement to License Exclusive, Worldwide Rights to Lebrikizumab - GlobeNewswire

Dermira Enters into Agreement to License Exclusive, Worldwide Rights to Lebrikizumab GlobeNewswire

Dermira’s QBREXZA™ (glycopyrronium) Cloth Is Now Available - GlobeNewswire

Dermira’s QBREXZA™ (glycopyrronium) Cloth Is Now Available GlobeNewswire

Dermira Reports Second Quarter 2018 Financial Results and Provides Corporate Update - GlobeNewswire

Dermira Reports Second Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire

Dermira Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update - GlobeNewswire

Dermira Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update GlobeNewswire

Eli Lilly acquires skin disease-focused Dermira in $1.1B deal - MedCity News

Eli Lilly acquires skin disease-focused Dermira in $1.1B deal MedCity News

It’s a pivotal moment for Dermira and its acne medication. What are its chances? - statnews.com

It’s a pivotal moment for Dermira and its acne medication. What are its chances? statnews.com

Spotlight on Dermira and the QBREXZA story - Dermatology Times

Spotlight on Dermira and the QBREXZA story Dermatology Times

Lilly bags late-phase Dupixent rival in $1.1B Dermira buyout - Fierce Biotech

Lilly bags late-phase Dupixent rival in $1.1B Dermira buyout Fierce Biotech

Almirall hands over $50M for European rights to Dermira's Dupixent challenger - Fierce Biotech

Almirall hands over $50M for European rights to Dermira's Dupixent challenger Fierce Biotech

Eli Lilly set to acquire Dermira, including lebrikizumab - PharmaTimes

Eli Lilly set to acquire Dermira, including lebrikizumab PharmaTimes

Dermira discontinues development of acne drug after two late-stage trials fail - statnews.com

Dermira discontinues development of acne drug after two late-stage trials fail statnews.com

Lilly Closes Dermira’s Menlo Park Facility, Cutting 163 Jobs in the Process - BioSpace

Lilly Closes Dermira’s Menlo Park Facility, Cutting 163 Jobs in the Process BioSpace

Roche sells off dermatitis drug to Dermira - BioPharma Dive

Roche sells off dermatitis drug to Dermira BioPharma Dive

Dermira shares double on positive eczema data - BioPharma Dive

Dermira shares double on positive eczema data BioPharma Dive

Dermira acne drug misses the mark, surprising investors - BioPharma Dive

Dermira acne drug misses the mark, surprising investors BioPharma Dive

Eli Lilly to gain late-stage IL-13 antibody lebrikizumab through $1.1-billion purchase of Dermira - FirstWord Pharma

Eli Lilly to gain late-stage IL-13 antibody lebrikizumab through $1.1-billion purchase of Dermira FirstWord Pharma

UCB and Dermira report positive Phase III trial results of Cimzia to treat chronic plaque psoriasis - Clinical Trials Arena

UCB and Dermira report positive Phase III trial results of Cimzia to treat chronic plaque psoriasis Clinical Trials Arena

Dermira drops UCB drug to fund other launches - BioPharma Dive

Dermira drops UCB drug to fund other launches BioPharma Dive

Pardes poaches former Dermira CEO Wiggans amid rocky ride at stock market - Fierce Biotech

Pardes poaches former Dermira CEO Wiggans amid rocky ride at stock market Fierce Biotech

Roche in part-sale of mixed bag lebrikizumab to Dermira - Fierce Biotech

Roche in part-sale of mixed bag lebrikizumab to Dermira Fierce Biotech

Sweating it out? Dermira’s armpit awareness push gets Qbrexza ready to roll - Fierce Pharma

Sweating it out? Dermira’s armpit awareness push gets Qbrexza ready to roll Fierce Pharma

No sweat? Dermira snags reps, sets price and plots branded ads for Qbrexza launch - Fierce Pharma

No sweat? Dermira snags reps, sets price and plots branded ads for Qbrexza launch Fierce Pharma

Evommune In-Licenses Three Development Programs Focused on Treating Inflammatory Conditions from Dermira, a Wholly-Owned Subsidiary of Eli Lilly and Company - PR Newswire

Evommune In-Licenses Three Development Programs Focused on Treating Inflammatory Conditions from Dermira, a Wholly-Owned Subsidiary of Eli Lilly and Company PR Newswire

Eli Lilly Bags Dermatology Company Dermira for $1.1 Billion - BioSpace

Eli Lilly Bags Dermatology Company Dermira for $1.1 Billion BioSpace

In FDA first, Dermira secures approval for excessive sweating drug - BioPharma Dive

In FDA first, Dermira secures approval for excessive sweating drug BioPharma Dive

Dermira Gains Rights to Roche IL-13 Inhibitor Lebrikizumab in Up-to-$1.4B Partnership - Genetic Engineering and Biotechnology News

Dermira Gains Rights to Roche IL-13 Inhibitor Lebrikizumab in Up-to-$1.4B Partnership Genetic Engineering and Biotechnology News

Cimzia Effectiveness Assessed for Chronic Plaque Psoriasis - Medical Professionals Reference

Cimzia Effectiveness Assessed for Chronic Plaque Psoriasis Medical Professionals Reference

Lilly expands dermatology portfolio with $1.1bn Dermira deal - PMLiVE

Lilly expands dermatology portfolio with $1.1bn Dermira deal PMLiVE

Dermira dumps acne drug after phase 3 flubs - Fierce Biotech

Dermira dumps acne drug after phase 3 flubs Fierce Biotech

Months after $1 billion buyout, Peninsula company, Lilly face generic challenge - The Business Journals

Months after $1 billion buyout, Peninsula company, Lilly face generic challenge The Business Journals

Why Dermira's Shares Are Doubling Today - The Motley Fool

Why Dermira's Shares Are Doubling Today The Motley Fool

FDA Approves Dermira’s Qbrexza for Treatment of Excessive Underarm Sweating - BioSpace

FDA Approves Dermira’s Qbrexza for Treatment of Excessive Underarm Sweating BioSpace

Evommune in-licenses assets from Lilly's Dermira - The Pharma Letter

Evommune in-licenses assets from Lilly's Dermira The Pharma Letter

Top Dermira, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant